CLINICAL_TRIALS
trial_result
· 2009-12-23
Clinical Trial Update: Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer [Phase 1]
Summary
Phase 1 study evaluating SU011248 in combination with docetaxel in patients with metastatic breast cancer has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Breast Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2009-12-23